Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.14
-0.31 (-4.16%)
At close: Sep 25, 2026, 4:00 PM EDT
7.07
-0.07 (-0.96%)
After-hours: Sep 25, 2026, 7:42 PM EDT

CRBP Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, CRBP stock has a consensus rating of "Strong Buy" and an average price target of $34.03. The average 1-year stock price forecast is 376.61% higher than the current stock price, while the lowest is $17.25 (+141.60%) and the highest is $48 (+572.27%).

Price Target: $34.03 (+376.61%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$17.25$34.03$34$48
Change+141.60%+376.61%+376.19%+572.27%

Analyst Ratings

The average analyst rating for CRBP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy999999
Buy111110
Hold000000
Sell000000
Strong Sell000000
Total10101010109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Buy
Reiterates
$30
BuyReiterates$30+320.17%Sep 15, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$35
BuyReiterates$35+390.20%Sep 14, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aSep 14, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$38
BuyMaintains$38+432.21%Sep 14, 2026
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$33
BuyReiterates$33+362.18%Sep 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.11M
Revenue Next Year
2.40M
from 1.11M
Increased by 116.00%
EPS This Year
-5.43
from -5.90
EPS Next Year
-5.51
from -5.43
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
881.71K----1.11M
Gross Profit
-35.56M-16.14M-31.17M-32.22M-70.10M1.11M
Gross Margin
-4,033.50%----100.00%
Operating Income
-55.99M-34.84M-45.08M-48.72M-85.31M-118.45M
Net Income
-45.64M-42.35M-44.60M-40.21M-78.54M-116.27M
EPS
-----5.90-5.43
Free Cash Flow
-----64.50M-121.08M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.0M
Avg1.1M
Lown/a

Revenue Growth

Revenue Growth20272028
High
1,700.0%
Avg
116.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-4.06
Avg-5.43
Low-6.81

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-